top of page

Prevention of Future Complications


Hypermobile Ehlers-Danlos syndrome (hEDS) is a connective tissue disorder that can affect joints, skin, blood vessels, digestion, the pelvic floor, and the nervous system. Because symptoms may change over time and can involve multiple body systems, prevention strategies are an important part of care. Prevention does not eliminate risks entirely, but it can reduce complications, slow secondary problems, and preserve quality of life.


The evidence base for hEDS prevention is still limited. Many recommendations are supported by clinical guidelines, expert consensus, small studies, or research in related conditions rather than large randomized trials. The following article notes where evidence is strong, emerging, based mainly on medical reasoning, or reported by patients.


Developmentally Stratified Strategies


Childhood

  • Physical and occupational therapy

    • What: Age-appropriate therapy focused on strengthening the core and limb muscles, improving proprioception (awareness of joint position), teaching safe movement patterns, and avoiding overextension of joints. Occupational therapy may address handwriting adaptations, grip strength, adaptive tools, and classroom seating to prevent fatigue.

    • Why: Helps reduce joint instability, recurrent injuries, pain, fatigue, and functional limitations. It may also help reduce risk of worsening movement patterns over time.

    • Evidence: Supported by clinical guidelines, expert consensus, and a growing but still limited rehabilitation literature.

  • Bracing and splints

    • What: Specialist-fitted supports for unstable joints such as knees, ankles, wrists, or fingers during sports, play, school tasks, or recovery from injury. Devices must be carefully fitted to avoid skin breakdown, pressure injury, or increased dependence on bracing when strengthening is also needed.

    • Why: Helps reduce recurrent injuries, pain, and joint strain during growth.

    • Evidence: Supported by clinical guidelines and expert consensus.

  • Regular surveillance during growth

    • What: Ongoing monitoring of posture, spine alignment, joint laxity, growth, pain, functional changes, fatigue, and school participation. Frequency should be individualized; some children need closer follow-up, while others may be monitored annually or at regular medical visits.

    • Why: Helps identify scoliosis, flat feet, worsening instability, pain amplification, or functional decline before problems become more disabling.

    • Evidence: Supported by expert consensus. A fixed every 3–6 month schedule is not universally required.


Adolescence

  • Advanced physiotherapy and activity modification

    • What: More intensive strengthening and balance work, endurance training, proprioceptive drills, and counseling on safe activity choices. Some high-impact or hyperextension-heavy activities, such as gymnastics, football, or long-distance running, may need to be modified or avoided depending on symptoms and injury history.

    • Why: Helps reduce recurrent dislocations, overuse injuries, deconditioning, chronic pain, and early disability.

    • Evidence: Supported by clinical guidelines, expert consensus, and limited rehabilitation studies.

  • Psychiatric and neurodevelopmental screening

    • What: Regular screening for anxiety, depression, ADHD, autism traits, school avoidance, sleep problems, and functional impairment using validated tools in schools and clinics when appropriate.

    • Why: Helps prevent untreated psychiatric or neurodevelopmental concerns from worsening into long-term disability, school withdrawal, social isolation, or reduced quality of life.

    • Evidence: The association between EDS/hEDS and anxiety, depression, ADHD, and autism is well documented. Evidence for specific screening and intervention schedules is more limited, but routine attention to these concerns is strongly supported.

  • Peer or group physiotherapy

    • What: Supervised exercise in groups, which may improve adherence, motivation, and social support.

    • Why: May reduce drop-out from therapy, isolation, and secondary disability.

    • Evidence: Based on medical reasoning and patient experience; direct research in hEDS is limited.


Adulthood

  • Lifelong tailored exercise and ergonomic adaptations

    • What: Ongoing exercise programs with a physical therapist or knowledgeable clinician, including resistance training, aerobic conditioning, and joint stabilization. Ergonomic strategies such as adjustable chairs, supportive footwear, adaptive tools, and proper desk setup may be important for work and daily living.

    • Why: Helps reduce chronic pain, workplace injury, deconditioning, and early disability.

    • Evidence: Supported by clinical guidelines, expert consensus, and limited rehabilitation studies.

  • Workplace accommodations and structured self-management

    • What: Adjustments such as flexible schedules, pacing strategies, ergonomic keyboards, sit-stand desks, planned rest breaks, symptom monitoring, and realistic goal setting.

    • Why: Helps reduce job loss, worsening pain, fatigue crashes, and secondary mental health decline.

    • Evidence: Supported by expert consensus, disability-management principles, and emerging research.

  • Digital health interventions and peer support

    • What: Online self-management programs, peer-led groups, and app-based symptom trackers.

    • Why: May reduce isolation and disengagement from care.

    • Evidence: Emerging or patient-reported, depending on the program. More hEDS-specific research is needed.


Body System–Specific Prevention


Musculoskeletal and Orthopedic

  • Physiotherapy tailored to hEDS

    • What: Exercises that avoid joint overextension, strengthen stabilizing muscles, improve posture, and use proprioceptive tools such as balance boards. Education on safe lifting, carrying, and sports participation is often included.

    • Why: Helps reduce instability, frequent subluxations or dislocations, pain, fatigue, and possible later joint degeneration.

    • Evidence: One of the best-supported areas of hEDS management, though the number of high-quality studies remains limited.

  • Orthoses, braces, and splints

    • What: Functional supports such as ankle-foot orthoses, wrist splints, finger splints, or knee braces, adjusted to activity level and used alongside strengthening when possible.

    • Why: Helps reduce microtrauma, joint misalignment, pain, and recurrent injury.

    • Evidence: Supported by clinical guidelines and expert consensus.

  • Prolotherapy and specialized motor training

    • What: Prolotherapy involves injections of an irritant solution intended to strengthen ligament attachments. Specialized motor training focuses on movement control, proprioception, and coordination.

    • Why: May help reduce worsening instability and chronic pain in selected patients.

    • Evidence: Limited. Prolotherapy has some supportive evidence but should not be presented as broadly proven. Motor-control training is consistent with rehabilitation principles but needs more hEDS-specific research.

  • Inspiratory muscle training

    • What: Structured breathing exercises using resistance devices to strengthen respiratory muscles.

    • Why: May help improve functional exercise capacity, fatigue, and exercise tolerance in some people.


Cardiovascular and Autonomic

  • Hydration, salt loading, compression, and exercise

    • What: Increasing fluids, increasing dietary salt when medically appropriate, wearing compression stockings or abdominal binders, and following a graduated exercise program. Many programs begin with reclined exercise such as rowing, swimming, or recumbent cycling before progressing upright.

    • Why: Helps reduce fainting, dizziness, falls, fatigue, and long-term cardiovascular deconditioning.

    • Evidence: Well supported for orthostatic intolerance and POTS management. Fluid and salt targets should be individualized; some guidance uses approximately 2 liters of fluid per day, while some patients are advised to use higher amounts under medical supervision.

  • Medication for autonomic symptoms

    • What: Prescribed when lifestyle changes are insufficient. Options may include fludrocortisone to increase blood volume, midodrine to tighten blood vessels, beta blockers to reduce heart rate surges, and ivabradine in selected patients.

    • Why: Helps reduce disabling autonomic symptoms, fainting, secondary injury, and deconditioning.

    • Evidence: Supported for POTS and orthostatic intolerance management, though medication choice should be individualized.

  • Tailored pharmacology

    • What: Customizing treatment to individual physiology, such as using heart-rate–lowering medication for prominent tachycardia or avoiding medications that may worsen orthostatic symptoms in some patients.

    • Why: Helps reduce trial-and-error side effects and poor symptom control.

    • Evidence: Supported by clinical reasoning, expert consensus, and evolving POTS literature.

  • Heat avoidance and cooling garments

    • What: Staying cool with vests, fans, shaded environments, cooling towels, or schedule adjustments to avoid heat-triggered autonomic crashes.

    • Why: Helps reduce fainting, dizziness, fatigue flares, and injury.

    • Evidence: Based mainly on clinical reasoning and patient experience.


Gastrointestinal and Nutrition

  • GI and nutrition screening

    • What: Medical review of symptoms such as constipation, reflux, nausea, abdominal pain, bloating, and swallowing difficulty. In children, growth charts and puberty timing are important. In adults, weight trends and selected blood tests, such as iron, B12, vitamin D, and calcium, may be useful when clinically indicated.

    • Why: Helps reduce malnutrition, anemia, osteoporosis risk, growth failure, and delayed recognition of treatable gastrointestinal disorders.

    • Evidence: Supported by clinical guidelines and expert consensus.

  • Avoiding unnecessary restrictive diets in children

    • What: Avoiding unnecessary gluten-free, dairy-free, low-FODMAP, low-histamine, or other restrictive diets unless medically indicated and supervised.

    • Why: Helps prevent nutrient deficiencies, growth problems, delayed puberty, food fear, and worsening feeding difficulties.

    • Evidence: Supported by pediatric nutrition principles and clinical reasoning.

  • Psychological support for avoidant restrictive food intake disorder (ARFID)

    • What: Treatment may include cognitive-behavioral therapy, dietitian input, medical monitoring, family involvement, and gradual food exposure when appropriate.

    • Why: Helps reduce severe feeding problems, malnutrition, functional decline, and need for more intensive nutritional support.

    • Evidence: Supported by ARFID treatment literature; hEDS-specific evidence is still emerging.

  • Mast cell–directed evaluation, diets, or medications

    • What: Evaluation for mast cell activation symptoms may be appropriate when symptoms are episodic and multisystem, such as flushing, hives, swelling, wheezing, gastrointestinal symptoms, or anaphylaxis-like episodes. Treatment may include antihistamines or other medications when clinically indicated. Low-histamine diets should generally be medically supervised, especially in children.

    • Why: May help reduce episodic multisystem symptoms and gastrointestinal distress in selected patients.

    • Evidence: Screening for mast cell activation is not recommended for every person with GI symptoms. Mast-cell–directed treatment should be individualized; evidence in hEDS remains limited.

  • Patient-led elimination diets

    • What: Identifying possible trigger foods through careful observation, ideally with clinician or dietitian guidance.

    • Why: May reduce persistent gastrointestinal distress in some people.

    • Evidence: Mostly patient-reported. Restrictive diets can create nutritional risk, so caution is especially important in children and adolescents.


Psychiatric and Neurodevelopmental

  • Routine anxiety, depression, ADHD, and autism-aware screening

    • What: Using validated questionnaires and clinical interviews in schools or clinics for children, adolescents, and adults when symptoms, functional concerns, or developmental differences are present.

    • Why: Helps reduce psychiatric disability, school withdrawal, social isolation, family stress, and delayed support.

    • Evidence: The association between EDS/hEDS and psychiatric and neurodevelopmental conditions is well documented. Evidence on the best screening schedule and intervention model is still developing.

  • CBT, family-based support, and coping-focused therapy

    • What: Cognitive-behavioral therapy for coping, pacing, pain-related fear, and functioning; family education and therapy to reduce stress and improve resilience; and support for grief, identity changes, medical trauma, or disability adjustment when relevant.

    • Why: Helps reduce anxiety, depression, avoidance, pain-related disability, and family strain.

    • Evidence: Supported by broader chronic illness, pain, and pediatric psychology literature; hEDS-specific intervention evidence is emerging.

  • Peer support and resilience training

    • What: Structured support groups, resilience workshops, and patient mentoring programs.

    • Why: May reduce isolation, hopelessness, and disengagement from care.

    • Evidence: Mostly patient-reported or based on clinical reasoning; more formal research is needed.


Rare and Serious Complications

  • Pelvic floor physiotherapy and constipation management

    • What: Pelvic floor therapy to improve coordination, strength, and relaxation; constipation treatment to reduce straining; and medical management of prolapse, incontinence, or pelvic pain when present.

    • Why: Helps reduce prolapse symptoms, incontinence, hernias, pelvic pain, and worsening bowel or bladder dysfunction.

    • Evidence: Supported by clinical consensus and pelvic health literature. Pelvic floor symptoms are common in EDS/hypermobility populations.

  • Dental surveillance and hygiene

    • What: Regular dental visits, orthodontic evaluation when needed, gentle oral care techniques, attention to gum recession or periodontal disease, and awareness that local anesthetic may be less effective in some patients.

    • Why: Helps reduce gum disease, tooth malalignment, temporomandibular joint dysfunction, pain, and dental complications.

    • Evidence: Supported by clinical guidelines and dental literature on EDS-related oral findings.

  • Eye exams and protective eyewear

    • What: Screening for refractive errors, dry eyes, strabismus, and other eye concerns; protective glasses for sports or activities with injury risk.

    • Why: Helps reduce vision problems, corneal injury, and missed ocular complications.

    • Evidence: Supported by clinical guidelines and expert consensus.

  • Yoga-based pelvic exercises

    • What: Gentle, adapted yoga routines aimed at pelvic support, relaxation, breathing, and body awareness.

    • Why: May help some people with pelvic floor tension, stress-related flares, or chronic pain.

    • Evidence: Mostly patient-reported. Safety caution: routines should avoid overstretching, joint strain, or positions that provoke subluxation, pain, dizziness, or pelvic symptoms.


Comorbidity Screening and Prevention

hEDS often overlaps with other medical conditions. These cannot always be avoided, but screening and early management can prevent complications from escalating.

  • POTS and orthostatic intolerance

    • What: Screening for dizziness, fainting, rapid heartbeat, exercise intolerance, heat intolerance, and symptoms that worsen when upright.

    • Why: Helps reduce injuries, fatigue, deconditioning, school or work impairment, and unnecessary emergency visits.

    • Evidence: Well supported by hEDS and POTS clinical literature.

  • Mast cell activation symptoms

    • What: Screening when symptoms suggest episodic multisystem reactions, such as hives, flushing, swelling, wheezing, gastrointestinal distress, or anaphylaxis-like episodes.

    • Why: May help reduce emergency episodes, food restriction, distress, and misdirected treatment in selected patients.

    • Evidence: Based on clinical guidance and evolving research. Routine MCAS testing for all GI symptoms is not recommended.

  • Psychiatric and neurodevelopmental comorbidities

    • What: Assessment for anxiety, depression, ADHD, autism, sleep problems, trauma symptoms, and functional impairment.

    • Why: Helps reduce school withdrawal, long-term disability, impaired relationships, and untreated distress.

    • Evidence: The association is well documented; optimal hEDS-specific prevention models need further research.

  • Bone fragility and low bone density

    • What: Monitoring vitamin D, calcium intake, puberty timing, growth, fracture history, height loss, and other risk factors. Bone density testing may be appropriate for those with atypical fractures, height loss, or other clinical concerns.

    • Why: Helps reduce fractures, osteoporosis risk, and missed endocrine or nutritional contributors.

    • Evidence: Supported by expert consensus and clinical guidelines for targeted screening.

  • Overlapping connective tissue syndromes

    • What: Genetic evaluation or specialist review for atypical features such as unusual vascular fragility, organ rupture, severe skin fragility, significant eye findings, or a concerning family history.

    • Why: Helps identify other connective tissue disorders that require targeted vascular, ocular, or organ surveillance.

    • Evidence: Strongly supported by clinical guidelines when red-flag features are present.

  • Aortic root dilation and cardiovascular surveillance

    • What: Echocardiography may be used when aortic root dilation is known or suspected, with follow-up frequency guided by findings and clinician judgment.

    • Why: Helps monitor rare but important cardiovascular complications.

    • Evidence: Supported by clinical guidelines for targeted surveillance rather than universal frequent testing in all patients.


Lifestyle and Self-Management

  • Exercise and pacing

    • What: Balancing activity with rest, using exercise to build strength without overuse, and pacing activity to reduce boom-and-bust cycles.

    • Why: Helps reduce overuse injuries, fatigue crashes, deconditioning, and cumulative joint strain.

    • Evidence: Supported by rehabilitation principles, clinical guidelines, and limited hEDS-specific studies.

  • Sleep hygiene

    • What: Regular sleep schedule, limiting screen time before bed, optimizing sleep environment, treating pain that interferes with sleep, and evaluating sleep disorders when symptoms suggest them.

    • Why: Helps reduce worsening fatigue, pain sensitivity, autonomic symptoms, and psychiatric symptoms.

    • Evidence: Supported by broader sleep and chronic illness literature; hEDS-specific prevention evidence is limited.

  • Ergonomic adaptations

    • What: Home, school, and workplace modifications such as adjustable furniture, supportive shoes, adaptive writing tools, mobility aids when needed, and task-specific equipment.

    • Why: Helps reduce repetitive strain injuries, pain flares, fatigue, and disability.

    • Evidence: Supported by expert consensus, occupational therapy practice, and emerging evidence.

  • Digital health programs

    • What: Online self-management tools, virtual support programs, symptom trackers, or structured education programs.

    • Why: May help sustain engagement, pacing, self-monitoring, and connection to support.

    • Evidence: Emerging; quality and usefulness vary by program.

  • Massage, meditation, adapted yoga, and mindfulness

    • What: Relaxation and body-awareness practices, used gently and modified for joint instability, pain, and autonomic symptoms.

    • Why: May reduce stress-related symptom flares, muscle tension, and distress.

    • Evidence: Mostly patient-reported or extrapolated from broader pain and stress-management research. Safety caution: movement-based practices should avoid overstretching and positions that trigger pain, dizziness, or instability.


Transition of Care and Equity

  • Early structured transition from pediatric to adult care

    • What: Transition planning during adolescence, readiness checklists, portable medical summaries, medication lists, emergency plans, and identification of adult clinicians before pediatric care ends.

    • Why: Helps reduce care gaps, loss of follow-up, emergency visits, and worsening unmanaged symptoms.

    • Evidence: Supported by transition-of-care principles and expert consensus.

  • Multidisciplinary care models

    • What: Coordinated care across primary care, specialists, physical and occupational therapy, psychology, nutrition, dentistry, and other relevant fields.

    • Why: Helps reduce fragmented care, conflicting advice, and untreated complications.

    • Evidence: Supported by expert consensus and emerging research; access remains a major barrier.

  • Patient navigators and peer educators

    • What: Support professionals and peer mentors who help patients understand care options, appointments, accommodations, and health-system navigation.

    • Why: May reduce disengagement and poor outcomes, especially in underserved groups.

    • Evidence: Mostly based on patient experience, health-equity reasoning, and broader chronic illness models.


Summary

Prevention in hypermobile Ehlers-Danlos syndrome is best understood as a lifespan process. In childhood, prevention emphasizes physical and occupational therapy, safe movement, supportive equipment when needed, and monitoring growth and function. In adolescence, it expands to include mental health and neurodevelopmental screening, safe activity choices, peer support, and transition planning. In adulthood, prevention focuses on long-term self-management, ergonomic adaptations, autonomic care, workplace support, and surveillance for systemic complications when indicated.


Across all ages, musculoskeletal strategies can reduce instability and injury; cardiovascular and autonomic measures can reduce fainting, falls, and deconditioning; gastrointestinal and nutritional screening can help prevent malnutrition and avoid unnecessary restriction; and psychiatric and neurodevelopmental support can reduce long-term disability and isolation. Dental, pelvic, eye, bone, and cardiovascular monitoring should be tailored to symptoms and risk factors rather than applied in the same way to every patient.


Because the research on hEDS prevention is still developing, it is helpful to think of these strategies as having different levels of support. Some are supported by clinical guidelines and expert consensus, some by small studies or emerging research, and others mainly by patient experience or medical reasoning. Together, these strategies highlight that prevention in hEDS is not about eliminating every risk, but about reducing complications, slowing secondary harm, and protecting quality of life across all stages of life.

Prevention

Please be aware that not all pages work with Microsoft Edge. Use Chrome, Safari or Firefox if you are having trouble.
© 2025 Kara Bowman. All rights reserved. Contact the author for permission to reprint.


 

bottom of page